Las Vegas, NV -- (SBWIRE) -- 10/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: OncoSec Medical Inc(OTCMKTS:ONCS), Online Tele-Solutions Inc.(OTCMKTS:TUNG), Biozone Pharmaceuticals Inc(OTCBB:BZNE), TNI BIOTECH INC(OTCMKTS:TNIB)
OncoSec Medical Inc(OTCMKTS:ONCS) was trading higher by +0.001 points or +0.39% to 0.258.So far, around 1.10 million shares have changed hands in this session. After opening at $0.26 , the stock hit as high as $0.26. However, it traded between $0.18and$0.49 over the last twelve months.
For How Long ONCS will Fight for Profitability? Read This Trend Analysis report
Online Tele-Solutions Inc.(OTCMKTS:TUNG) was at $0.20.Around 115.85k shares have been traded, versus an-average trading volume of 91,155.00 shares. The company is now valued at around $13.75 million.
Can TUNG Show a Strong Recovery? Find out in This Research Report
Biozone Pharmaceuticals Inc(OTCBB:BZNE) moved +5.15 per cent higher at $0.510 and is trading between $0.49 and $0.54 after opening the day at $0.50. Its performance over the last five days remained +6.03%, which stands at -26.09% for a month. Going back further than one month, 1-year performance after recent close was -84.31%.
Will BZNE Continue To Move Higher? Find Out Here
TNI BIOTECH INC(OTCMKTS:TNIB)’s shares rose today, gaining +36.72 per cent to $1.75. The stock is up around -53.33% in 2013 and -53.33% for the last 12 months. Around 152,837.00 shares changed hands so far in this session compared to an-average trading volume of 141,974.00 shares.
Why Should Investors Buy TNIB After The Recent Gain? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)